Recent publications by Researchers affiliated with the Centre for Tropical Medicine and Global Health
Clinicians in low- and middle-income settings need better access to point-of-care haemoglobin tests for identifying and managing children and pregnant women with severe anaemia.
South A. et al, (2025), Tropical medicine & international health : TM & IH
Comparative performance of the InBios SCoV-2 DetectTM IgG ELISA and the in-house KWTRP ELISA in detecting SARS-CoV-2 spike IgG antibodies in Kenyan populations
Kutima B. et al, (2024), Wellcome Open Research, 9, 349 - 349
Factors affecting haemoglobin dynamics in African children with acute uncomplicated Plasmodium falciparum malaria treated with single low-dose primaquine or placebo
Onyamboko MA. et al, (2023), BMC Medicine, 21
Pharmacokinetics of single low dose primaquine in Ugandan and Congolese children with falciparum malaria
Mukaka M. et al, (2023), eBioMedicine, 96, 104805 - 104805
Non-O ABO blood group genotypes differ in their associations with Plasmodium falciparum rosetting and severe malaria.
Opi DH. et al, (2023), PLoS genetics, 19
SARS-CoV-2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February-December 2022.
Kagucia EW. et al, (2023), Influenza and other respiratory viruses, 17
Blood transfusion for children in sub-Saharan Africa: 200 years on.
Uyoga S. et al, (2023), The Lancet. Child & adolescent health, 7, 525 - 526
Safety of age-dosed, single low-dose primaquine in children with glucose-6-phosphate dehydrogenase deficiency who are infected with Plasmodium falciparum in Uganda and the Democratic Republic of the Congo: a randomised, double-blind, placebo-controlled, non-inferiority trial
Taylor WR. et al, (2023), The Lancet Infectious Diseases, 23, 471 - 483
High false discovery rate of the Architect anti-HCV screening test in blood donors in Uganda and evaluation of an algorithm for confirmatory testing.
Lucey O. et al, (2022), Vox sanguinis
Revealing the extent of the first wave of the COVID-19 pandemic in Kenya based on serological and PCR-test data
Ojal J. et al, (2022), Wellcome Open Research, 6, 127 - 127
Sickle cell anaemia and severe Plasmodium falciparum malaria: a secondary analysis of the Transfusion and Treatment of African Children Trial (TRACT)
Uyoga S. et al, (2022), The Lancet Child & Adolescent Health, 6, 606 - 613
Substantial misdiagnosis of severe malaria in African children
White NJ. et al, (2022), The Lancet, 400, 807 - 807
Epidemiological impact and cost-effectiveness analysis of COVID-19 vaccination in Kenya.
Orangi S. et al, (2022), BMJ global health, 7
BIRC6 modifies risk of invasive bacterial infection in Kenyan children.
Gilchrist JJ. et al, (2022), eLife, 11
Improving the diagnosis of severe malaria in African children using platelet counts and plasma Pf HRP2 concentrations
Watson JA. et al, (2022), Science Translational Medicine, 14
A Clinical and Physiological Prospective Observational Study on the Management of Pediatric Shock in the Post-Fluid Expansion as Supportive Therapy Trial Era.
Obonyo NG. et al, (2022), Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 23, 502 - 513
Hepcidin regulation in Kenyan children with severe malaria and non-typhoidal Salmonella bacteremia.
Abuga KM. et al, (2022), Haematologica, 107, 1589 - 1598